DEKK-TEC, INC.
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1983-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.dekk-tec.com
Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)β’ Click on a phase to view related trials
DM-CHOC-PEN for Brain Tumors in AYA Subjects
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- DEKK-TEC, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03668847
- Locations
- πΊπΈ
Tulane University Medical Center, New Orleans, Louisiana, United States
DM-CHOC-PEN Plus Radiation for Brain Tumors
- Conditions
- Advanced Cancer
- Interventions
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- DEKK-TEC, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT03371004
- Locations
- πΊπΈ
Tulane University Medical Center, New Orleans, Louisiana, United States
πΊπΈTulane University Medical School, New Orleans, Louisiana, United States
πΊπΈDetroit Clinical Research Centers, Detroit, Michigan, United States
A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers
- Conditions
- Advanced Cancer
- First Posted Date
- 2016-09-05
- Last Posted Date
- 2020-08-18
- Lead Sponsor
- DEKK-TEC, Inc.
- Registration Number
- NCT02889445
- Locations
- πΊπΈ
Detroit Clinical Research Centers, Detroit, Michigan, United States
Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors
- Conditions
- Primary Brain TumorsMetastatic Malignant Neoplasm to Brain
- Interventions
- Drug: 4-Demethyl-4-cholestryloxycarbonylpenclomedine
- First Posted Date
- 2014-01-16
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- DEKK-TEC, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT02038218
- Locations
- πΊπΈ
Tulane University Medical Center, New Orleans, Louisiana, United States
πΊπΈDetroit Clinical Research Centers, Lansing, Michigan, United States
πΊπΈThe University of Texas Health Science Center, Houston, Texas, United States
Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer"
- First Posted Date
- 2013-11-06
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- DEKK-TEC, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT01976910
- Locations
- πΊπΈ
Tulane University Medical School, New Orleans, Louisiana, United States
- Prev
- 1
- 2
- Next